{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:59:17Z","timestamp":1791158357982,"version":"4.1.0"},"reference-count":47,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T00:00:00Z","timestamp":1306195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2011,7]]},"abstract":"<jats:p>\n                    <jats:bold>Aim:<\/jats:bold>\n                    This\n                    <jats:italic>post hoc<\/jats:italic>\n                    analysis compared the lipid\u2010altering efficacy and safety of ezetimibe 10 mg plus statin (EZE\/statin) vs. statin monotherapy in hypercholesterolaemic patients with and without diabetes.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    A pooled analysis of 27 previously published, randomized, double\u2010blind, active\u2010 or placebo\u2010controlled clinical trials comprising 21 794 adult patients with (n = 6541) and without (n = 15253) diabetes receiving EZE\/statin or statin alone for 4\u201324 weeks evaluated percentage change from baseline in lipids and other parameters. Consistency of the treatment effect across the subgroups was tested using treatment \u00d7 subgroup interaction. No multiplicity adjustments were made.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Treatment effects within both subgroups were generally consistent with the overall population. EZE\/statin was more effective than statin alone in improving low\u2010density lipoprotein cholesterol (LDL\u2010C), total cholesterol (TC), high\u2010density lipoprotein cholesterol (HDL\u2010C), triglycerides (TGs), non\u2010HDL\u2010C, apolipoprotein (apo) B and high\u2010sensitivity C\u2010reactive protein (hs\u2010CRP) in the overall population and both subgroups. Patients with diabetes achieved significantly larger reductions in LDL\u2010C, TC and non\u2010HDL\u2010C compared with non\u2010diabetic patients. Incidences of adverse events or creatine kinase elevations were similar between groups. A small but significantly higher incidence of alanine aminotransferase or aspartate aminotransferase elevations was seen in patients receiving EZE\/statin (0.6%) vs. statin monotherapy (0.3%) in the overall population.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Treatment with EZE\/statin vs. statin monotherapy provided significantly larger reductions in LDL\u2010C, TC, TG, non\u2010HDL\u2010C, apo B and hs\u2010CRP and significantly greater increases in HDL\u2010C, with a similar safety profile in patients with and without diabetes. Reductions in LDL\u2010C, TC and non\u2010HDL\u2010C were larger in patients with diabetes than in patients without diabetes.\n                  <\/jats:p>","DOI":"10.1111\/j.1463-1326.2011.01383.x","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T08:07:23Z","timestamp":1298016443000},"page":"615-628","source":"Crossref","is-referenced-by-count":72,"title":["Lipid\u2010altering efficacy and safety profile of combination therapy with ezetimibe\/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials"],"prefix":"10.1111","volume":"13","author":[{"given":"L. A.","family":"Leiter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Betteridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Farnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. R.","family":"Guyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. O.","family":"Johnson\u2010Levonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Brudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,5,24]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.548206"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.4.614"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet1066"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7134.823"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60104-X"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJR.0b013e3283294b1d"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.1.160"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-9018"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000133317.49796.0E"},{"key":"e_1_2_8_12_2","first-page":"88","article-title":"Guidelines on diabetes, pre\u2010diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).","volume":"28","author":"Ryden L","year":"2007","journal-title":"Eur Heart J"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosissup.2008.05.012"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2006.10.028"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0504-0"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.90376.2008"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.1.53"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61965-6"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.08.012"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.03.004"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.07.023"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.4065\/80.5.587"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.4065\/79.5.620"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02610-4"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2004.11.016"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)03236-8"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(02)00803-5"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000068312.21969.C8"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)81639-X"},{"key":"e_1_2_8_30_2","first-page":"772","article-title":"Efficacy and safety of coadministration of ezetimibe and simvastatin in African\u2010American patients with primary hypercholesterolemia.","volume":"98","author":"Rodney RA","year":"2006","journal-title":"J Natl Med Assoc"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X382004"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2005.01.022"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2005.00565.x"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2005.00714.x"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2007.00725.x"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02022.x"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02774-1"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.11.023"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X132721"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.4065\/81.12.1579"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.09.075"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.09.076"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.05.003"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.10.029"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2004.00420.x"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.02.059"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.02.060"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.03.052"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1326.2011.01383.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/j.1463-1326.2011.01383.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:45:17Z","timestamp":1761885917000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/j.1463-1326.2011.01383.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,24]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["10.1111\/j.1463-1326.2011.01383.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1463-1326.2011.01383.x","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,24]]}}}